NLRP3 and urinary bladder carcinoma: This review focuses on summarizing the structure and activation mechanisms of the NLRP3 inflammasome and elucidates its role in urogenital system tumors, such as prostate and bladder cancers, highlighting its potential as a therapeutic target.